콘텐츠로 건너뛰기
Merck
  • Investigation of cell envelope damage to Pseudomonas aeruginosa and Enterobacter cloacae by dibromopropamidine isethionate.

Investigation of cell envelope damage to Pseudomonas aeruginosa and Enterobacter cloacae by dibromopropamidine isethionate.

Journal of pharmaceutical sciences (1993-09-01)
R M Richards, J Z Xing, D W Gregory, D Marshall
초록

Electron micrographs of log-phase Pseudomonas aeruginosa and Enterobacter cloacae cultured for 4 h in the presence of subinhibitory concentrations of dibromopropamidine isethionate indicate that this antibacterial agent can cause marked damage to the cell envelope structures of both species. This result provides an explanation of how dibromopropamidine can enhance the uptake and thus the activity of a second antibacterial agent used in combination with it.

MATERIALS
제품 번호
브랜드
제품 설명

Dibrompropamidine for system suitability, European Pharmacopoeia (EP) Reference Standard
Dibrompropamidine diisetionate, European Pharmacopoeia (EP) Reference Standard